Study of GORE® BIO-A® Fistula Plug for Use in Anal Fistula Repair
Status: | Completed |
---|---|
Conditions: | Hospital, Gastrointestinal |
Therapuetic Areas: | Gastroenterology, Other |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 10/19/2013 |
Start Date: | March 2011 |
End Date: | June 2014 |
Contact: | Vicki Higham, MSN |
Email: | vhigham@wlgore.com |
Phone: | 410-506-8353 |
Multicenter,Prospective, Observational Study of GORE® BIO-A® Fistula Plug for Use in Anal Fistula Repair
The primary purpose of this prospective, multicenter, observational, single arm study is to
further substantiate efficacy of the GORE® BIO-A® Fistula Plug when used as a soft tissue
reinforcement of anal fistula repair and healing.
Primary outcome variable is healing at the final follow up visit.
Inclusion Criteria:
- Transsphincteric fistula consisting of 1 tract(defined as a fistula which would not
be amenable to fistulotomy); determined during operative procedure
- Likely cryptoglandular origin
- Must be at least 18 years of age
- Patients informed about the study, and will have read, understood and signed the
patient informed consent and authorization to use PHI data, as applicable
- Patients willing and able to submit to postoperative follow-up evaluations
Exclusion Criteria:
- Crohn's Disease
- Evidence of on-going local infection
- History of more than 2 prior definitive repair attempts; repair attempt is defined as
any of the following: advancement flap, cutting seton, fistulotomy, fistulectomy,
fibrin glue, anal fistula plug, LIFT
- Superficial fistulas without any muscle involvement
- Fistulae of traumatic origin, including obstetric
- Intersphincteric fistulas that would be candidate for fistulotomy
- Horseshoe or multi-tract fistulas
- Ano-vaginal or recto-vaginal fistulas
- Anastomotic fistulas (ileo-anal, colo-anal)
- A wound-healing or autoimmune disorder (including insulin-dependent diabetics)
- Subjects who are immunocompromised such as, with HIV, or currently receiving chemo or
radiation therapy
- Subjects who are immunosuppressed, e.g. transplant patients, patients taking
steroids, TNF agents, methotrexate
- History of prior or current pelvic radiation
- Difficulty comprehending or complying with the study (in surgeon's opinion)
We found this trial at
1
site
101 The City Drive South
Orange, California 92868
Orange, California 92868
714-456-7890
University of California, Irvine Medical Center We are UC Irvine Health. We are a devoted...
Click here to add this to my saved trials